Showing 1-5 of 20 population, health plan & member management & analytics:
Expert Praises Proposed Federal Rule to Strengthen Behavioral Health Parity

HealthLeaders Christopher Cheney August 1, 2023 Read the full article >> A new proposal from the Biden administration to strengthen parity for behavioral health services with physical health services is a step in the right direction, according to Carl Marci, MD, a psychiatrist at Massachusetts General Hospital and an assistant professor of psychiatry at Harvard Medical School.[…]

12 New Ways Companies Are Helping to Improve Adherence

PM360 July 13, 2023 Read the full article>> Reasons for Discontinuation (RfD) Analytics Report An estimated 50% of patients with a prescription for a chronic condition stop taking it within the first year, leading to worse outcomes and nearly $250 billion lost revenue annually for the pharmaceutical industry. To combat this, OM1 launched its Reasons for Discontinuation[…]

DataDerm Update

Practical Dermatology May 8, 2023 Vishal Anil Patel, MD Read the full article>>  I recently interviewed Marta Jane Van Beek, MD, MPH, the C. William Hanke associate professor of dermatologic surgery and director of the division of dermatologic surgery and cutaneous oncology within the department of dermatology at the University of Iowa Carver College of[…]

Advancing Personalized Medicine for Health Plans: How AI and RWE can improve outcomes, reduce costs, and improve member engageme

Tue, Oct 18, 2022 11:00 AM – 12:00 PM EDT Presenter: Joseph Zabinski, Senior Director, AI & Precision Medicine, OM1 Register >> As population health moves towards personalized, precision medicine, optimizing treatment options and reducing ineffective care will be critical to plans’ success and differentiation in highly competitive environments. Real-world evidence drawn from deep datasets[…]

Addressing Equity in Research with Real-World Data

Thu, May 26, 2022 11:00 AM – 12:00 PM EDT Register>> As the call for more diversity in clinical research grows, new approaches are needed to ensure patients of different genders, ethnicities, income brackets, and other under-represented populations are included in the evaluation of treatment access, effectiveness, and safety. Real-world data (RWD) can help with[…]